Accéder au contenu
Merck
  • GPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS.

GPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS.

Atherosclerosis (2015-03-22)
Zhongyang Lu, Yanchun Li, Junfei Jin, Xiaoming Zhang, Yusuf A Hannun, Yan Huang
RÉSUMÉ

Increased levels of both saturated fatty acids (SFAs) and lipopolysaccharide (LPS) are associated with type 2 diabetes. However, it remains largely unknown how SFAs interact with LPS to regulate inflammatory responses in microvascular endothelial cells (MIC ECs) that are critically involved in atherosclerosis as a diabetic complication. In this study, we compared the effects of LPS, palmitic acid (PA), the most abundant saturated fatty acid, or the combination of LPS and PA on interleukin (IL)-6 expression by MIC ECs and explored the underlying mechanisms. Human cardiac MIC ECs were treated with LPS, PA and LPS plus PA and the regulatory pathways including receptors, signal transduction, transcription and post-transcription, and sphingolipid metabolism for IL-6 expression were investigated. G protein-coupled receptor (GPR)40 or free fatty acid receptor 1 (FFA1), but not toll-like receptor 4, was involved in PA-stimulated IL-6 expression. PA not only stimulated IL-6 expression by itself, but also remarkably enhanced LPS-stimulated IL-6 expression via a cooperative stimulation on mitogen-activated protein kinase and nuclear factor kappa B signaling pathways, and both transcriptional and post-transcriptional activation. Furthermore, PA induced a robust neutral sphingomyelinase (nSMase)-mediated sphingomyelin hydrolysis that was involved in PA-augmented IL-6 upregulation. PA boosted inflammatory response of microvascular endothelial cells to LPS via GPR40 and nSMase.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
(L)-Dehydroascorbic acid
Sigma-Aldrich
Fumonisin B1 from Fusarium moniliforme, ≥98% (HPLC)
Sigma-Aldrich
Dicyanocobinamide, ≥93%
Sigma-Aldrich
SP600125, ≥98% (HPLC)
Sigma-Aldrich
Myriocin from Mycelia sterilia, ≥98% (HPLC), powder
Sigma-Aldrich
Dehydro-L-(+)-ascorbic acid dimer, ≥80% (enzymatic)
Supelco
Fumonisin B1 solution, ~50 μg/mL in acetonitrile: water, analytical standard
Supelco
Fumonisin B1, reference material, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Smpd2
Sigma-Aldrich
MISSION® esiRNA, targeting human SMPD2